FindMyRecallSubscribe
Class I: serious health riskTerminated

A&H Focal GERMANY NIUBIAN tablets Recall

GERMANY NIUBIAN tablets, 3000mg, 10-count bottle, labeling is in foreign language

A&H Focal Inc. · Staten Island, NY

Risk level
Class I
Reported by FDA
Feb 7, 2018
Recall ID
D-0556-2018
Check your lot numberHow we source this data

Summary

A&H Focal recalled GERMANY NIUBIAN tablets starting Mar 7, 2017. The FDA classified it as Class I (serious health risk) and published enforcement report D-0556-2018 on Feb 7, 2018. Reason: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall. Status: Terminated.

Why it was recalled

Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.

Product description

GERMANY NIUBIAN tablets, 3000mg, 10-count bottle, labeling is in foreign language

Lot numbers, UPCs & expiration codes

All Lots

Where it was sold

NY and NJ through six retail stores named "Asian Food Markets"

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0556-2018
Classification
Class I
Status
Terminated
Recall initiated
Mar 7, 2017
FDA report date
Feb 7, 2018
Quantity
unknown
Recall type
Voluntary: Firm initiated
Recalling firm
A&H Focal Inc.

Original FDA data

Every field from FDA enforcement report D-0556-2018, exactly as published.

Show all FDA fields
City
Staten Island
State
NY
Status
Terminated
Country
United States
Event ID
76644
Address
119 Linwood Ave
Code information
All Lots
Postal code
10305-4445
Report date
Feb 7, 2018
Product type
Drugs
Recall number
D-0556-2018
Classification
Class I
Recalling firm
A&H Focal Inc.
Product quantity
unknown
Termination date
Jun 14, 2019
Reason for recall
Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.
Voluntary / mandated
Voluntary: Firm initiated
Product description
GERMANY NIUBIAN tablets, 3000mg, 10-count bottle, labeling is in foreign language
Distribution pattern
NY and NJ through six retail stores named "Asian Food Markets"
Recall initiation date
Mar 7, 2017
Initial firm notification
Press Release
Center classification date
Feb 28, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0556-2018, published Feb 7, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls